Empagliflozin: cardiorenal benefits in patients with type 2 diabetes, beyond glycemic control

Activity: Talk or presentation › Lecture and oral contribution

Period2020
Event titlePeruvian Diabetes Association
Event typeConference
Degree of RecognitionInternational